Top Markets
#1 Siacoin Siacoin +14.92%
#2 B3 (Base) B3 (Base) +8.29%
#3 The Black Bull The Black Bull +4.42%
#4 MVL MVL +4.32%
#5 TROLL TROLL +4.30%
#6 BORA BORA +3.14%
#7 Power Ledger Power Ledger +2.58%
#8 Pieverse Pieverse +2.47%
#9 Vision Vision +2.10%
#10 WYDE: End Hunger WYDE: End Hunger +2.00%
Coin of the day
Siacoin Siacoin
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Energenesis Biomedical CO.,LTD. Energenesis Biomedical CO.,LTD.

Energenesis Biomedical CO.,LTD.

6657
Classement en actions #22642
Energenesis Biomedical CO.,LTD., a firm established in 2012 and headquartered... Energenesis Biomedical CO.,LTD., a firm established in 2012 and headquartered in Taipei, Taiwan, is an active participant in the biomedicine sector. The company specializes in the development of a diverse range of medical solutions and research materials. Its primary pharmaceutical pipeline includes ENERGI-F703, which is currently undergoing Phase II clinical trials for the treatment of diabetic foot ulcers, and ENERGI-F701, a topical solution for addressing alopecia that is also in its second phase of clinical assessment. The comprehensive portfolio of therapeutic agents further encompasses: ENERGI-F711, formulated as a cream for burns. ENERGI-F702, designed to combat metabolic diseases. ENERGI-F704, targeting inflammatory bowel disease. ENERGI-F708, for the management of asthma. ENERGI-F705, aimed at controlling Parkinson's disease. ENERGI-F707, addressing mitochondrial deficiencies. ENERGI-F706, used to treat cachexia. ENERGI-F709, which serves as a vaccine adjuvant. ENERGI-F710, intended for the regulation of blood phosphate levels. Beyond its therapeutic developments, Energenesis Biomedical also provides a selection of scientific research products, including reagents for Western blotting, cell culture supplements, components for protein isolation and quantification, various laboratory dyes, and buffer solutions.
Prix de l'action
$0.97305026
Dernière synchronisation: 2026-08-21
Capitalisation boursière
$85.54M
Changement (1 jour)
1.16%
Changement (1 an)
-50.40%
Pays
TW
Échange Energenesis Biomedical CO.,LTD. (6657)

Catégorie

Healthcare
EPS pour Energenesis Biomedical CO.,LTD. (6657)
EPS au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Energenesis Biomedical CO.,LTD., l’EPS actuel de la société (TTM) est de 0. À la fin de 2026, la société avait un EPS de 0 égal à celui de 2026, qui était de 0.
Historique de l'EPS de Energenesis Biomedical CO.,LTD. de 2026 à 2026
EPS à la fin de chaque année
Année EPS Changez
Pas assez de données pour les dates fournies.
EPS pour des entreprises ou concurrents similaires
Entreprise EPS Différence d’EPS Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $-5.29 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH